Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in Glioma
Amy Haseley(Neurological Surgery), Balveen Kaur(Augusta University), Lianbo Yu(The Ohio State University), Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Kazuhiko Kurozumi(Okayama University), Jianhua Yu(University of California, Irvine), Sean Boone(Okayama University), Ji Young Yoo(The University of Texas MD Anderson Cancer Center), Joseph C. Glorioso(Okayama University), Jeffrey Wojton(The Ohio State University Wexner Medical Center)
Cited by 58
Related Papers
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
|Proceedings of the National Academy of Sciences|2012|1.5k
Landscape of Microsatellite Instability Across 39 Cancer Types
|JCO Precision Oncology|2017|1.5k
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
|Nature Genetics|2000|1.4k
Evidence for discrete stages of human natural killer cell differentiation in vivo
|The Journal of Experimental Medicine|2006|429